Press Releases

Press Releases

Johnson & Johnson today announced an expanded partnership with Save the Children to support children impacted by the Syrian refugee crisis and strengthen long-term resiliency in their communities. The $1.75 million commitment was announced in advance of Save the Children's third annual Illumination Gala in New York City. "The distressing…

Press Releases

The Australian Council on Healthcare Standards (ACHS) has awarded the ACHS International Medal 2015 to Dr Mohammed Sahadullafrom Kerala, India in recognition of his ‘outstanding contribution at an international level to improving quality and safety in health services’.  This is the second time ACHS has presented the award. “Dr Sahadullais…

Press Releases

Pharmintech, the triennial trade fair dedicated to the technology supply chain for the pharmaceutical, parapharmaceutical, nutraceutical and cosmeceutical industry and organised by BolognaFiere, returns to Bologna from 13th-15th April 2016 in partnership with UCIMA - Unione Costruttori Italiani Macchine Automatiche per il Confezionamento e l’Imballaggio (Union of Italian Manufacturers of…

Press Releases

Gilead Sciences, Inc. today announced it will present 32 scientific presentations related to its approved medicines and investigational therapies for the treatment of chronic hepatitis C virus (HCV) infection at The Liver Meeting 2015 in San Francisco. Data include results from studies of Harvoni® (ledipasvir/sofosbuvir) and Sovaldi® (sofosbuvir) that advance…

Press Releases

Arrowhead Research Corporation, a biopharmaceutical company developing targeted RNAi therapeutics, presents data at the AASLD Liver Meeting 2015® in an oral presentation and a poster showing that ARC-520, its drug candidate against chronic hepatitis B infection (HBV), leads to robust, sustained anti-viral effects in chimpanzees with chronic HBV. Arrowhead also…

Press Releases

Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced that it will participate at the following upcoming investor conferences in November and December 2015. Jim Kelly, Vanda's Senior Vice President and Chief Financial Officer, will…

Press Releases

PAREXEL International Corporation, a leading global biopharmaceutical services provider, and Kyoto Pharmaceutical University (KPU), a private pharmacy and science university, today announced the new Joint Program for Clinical Research and Clinical Trial Management. The academic program offers undergraduate students an accredited, seven-week course designed to prepare them for careers in…

Press Releases

Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Harvoni® (ledipasvir/sofosbuvir) for expanded use in patients with genotype 4, 5 and 6 chronic hepatitis C virus (HCV) infection and in patients co-infected with HIV. In addition, Harvoni plus ribavirin (RBV) for 12 weeks was approved…

Press Releases

Eiger BioPharmaceuticals, Inc. announced that it has acquired an exclusive license to technology for targeting effects of leukotriene B4 (LTB4) to reverse structural tissue changes and improve lymphatic function, providing a potential therapeutic approach for treating lymphedema.  The technology was invented by Dr. Stanley Rockson, MD, Professor of Cardiovascular Medicine…

Press Releases

Ascendis Pharma A/S, a clinical stage biotechnology company that applies its innovative TransCon technology to address significant unmet medical needs, today announced plans to present at an upcoming investor conference. Event:     2015 Stifel Healthcare Conference Location:  New York Palace Hotel, New York, NY Date:   Wednesday, November 18, 2015  Time: …